{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Argemone albiflora", "Nepeta hindustana", "Vitex negundo", "multiple sclerosis", "neuroprotective agents", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35268709", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["1608", "10.3390/molecules27051608"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "28"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Vivo Assessment of the Ameliorative Impact of Some Medicinal Plant Extracts on Lipopolysaccharide-Induced Multiple Sclerosis in Wistar Rats.", "Abstract": {"AbstractText": ["Multiple sclerosis is a chronic autoimmune disorder that leads to the demyelination of nerve fibers, which is the major cause of non-traumatic disability all around the world. Herbal plants <i>Nepeta hindustana</i> L., <i>Vitex negundo</i> L., and <i>Argemone albiflora</i> L., in addition to anti-inflammatory and anti-oxidative effects, have shown great potential as neuroprotective agents. The study was aimed to develop a neuroprotective model to study the effectiveness of herbal plants (<i>N. hindustana</i>, <i>V. negundo</i>, and <i>A. albiflora</i>) against multiple sclerosis. The in vivo neuroprotective effects of ethanolic extracts isolated from <i>N. hindustana</i>, <i>V. negundo</i>, and <i>A. albiflora</i> were evaluated in lipopolysaccharides (LPS) induced multiple sclerosis Wistar rat model. The rat models were categorized into seven groups including group A as normal, B as LPS induced diseased group, while C, D, E, F, and G were designed as treatment groups. Histopathological evaluation and biochemical markers including stress and inflammatory (MMP-6, MDA, TNF-\u03b1, AOPPs, AGEs, NO, IL-17 and IL-2), antioxidant (SOD, GSH, CAT, GPx), DNA damage (Isop-2\u03b1, 8OHdG) as well as molecular biomarkers (RAGE, Caspase-8, p38) along with glutamate, homocysteine, acetylcholinesterase, and myelin binding protein (MBP) were investigated. The obtained data were analyzed using SPSS version 21 and GraphPad Prism 8.0. The different extract treated groups (C, D, E, F, G) displayed a substantial neuroprotective effect regarding remyelination of axonal terminals and oligodendrocytes migration, reduced lymphocytic infiltrations, and reduced necrosis of Purkinje cells. The levels of stress, inflammatory, and DNA damage markers were observed high in the diseased group B, which were reduced after treatments with plant extracts. The antioxidant activity was significantly reduced in diseased induced group B, however, their levels were raised after treatment with plant extract. Group F (a m\u00e9lange of all the extracts) showed the most significant change among all other treatment groups (C, D, E, G). The communal dose of selected plant extracts regulates neurodegeneration at the cellular level resulting in restoration and remyelination of axonal neurons. Moreover, 400 mg/kg dose of three plants in conjugation (Group F) were found to be more effective in restoring the normal activities of all measured parameters than independent doses (Group C, D, E) and is comparable with standard drug nimodipine (Group G) clinically used for the treatment of multiple sclerosis. The present study, for the first time, reported the clinical evidence of <i>N. hindustana</i>, <i>V. negundo</i>, and <i>A. albiflora</i> against multiple sclerosis and concludes that all three plants showed remyelination as well neuroprotective effects which may be used as a potential natural neurotherapeutic agent against multiple sclerosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore 54000, Pakistan."}], "LastName": "Rasool", "ForeName": "Rabia", "Initials": "R"}, {"Identifier": ["0000-0002-1614-6456"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore 54000, Pakistan."}], "LastName": "Ullah", "ForeName": "Inam", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore 54000, Pakistan."}], "LastName": "Shahid", "ForeName": "Samiah", "Initials": "S"}, {"Identifier": ["0000-0002-4095-6467"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore 54000, Pakistan."}], "LastName": "Mubeen", "ForeName": "Bismillah", "Initials": "B"}, {"Identifier": ["0000-0002-8913-0826"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Imam", "ForeName": "Syed Sarim", "Initials": "SS"}, {"Identifier": ["0000-0002-0922-9819"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Alshehri", "ForeName": "Sultan", "Initials": "S"}, {"Identifier": ["0000-0002-9179-4373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": ["0000-0003-4007-4023"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia."}], "LastName": "Alzarea", "ForeName": "Sami I", "Initials": "SI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Abbottabad University of Science and Technology (AUST), Abbottabad 22310, Pakistan."}], "LastName": "Murtaza", "ForeName": "Bibi Nazia", "Initials": "BN"}, {"Identifier": ["0000-0003-4112-0925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Nadeem", "ForeName": "Muhammad Shahid", "Initials": "MS"}, {"Identifier": ["0000-0003-1881-5219"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Kazmi", "ForeName": "Imran", "Initials": "I"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}], "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jellinger K. Multiple Sclerosis: Tissue Destruction and Repair. Eur. J. Neurol. 2002;9:187. doi: 10.1046/j.1468-1331.2002.0329a.x.", "ArticleIdList": ["10.1046/j.1468-1331.2002.0329a.x"]}, {"Citation": "Huang W.J., Chen W.W., Zhang X. Multiple sclerosis: Pathology, diagnosis and treatments. Exp. Ther. Med. 2017;13:3163\u20133166. doi: 10.3892/etm.2017.4410.", "ArticleIdList": ["10.3892/etm.2017.4410", "PMC5450788", "28588671"]}, {"Citation": "Celius E., Smestad C. Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades. Acta Neurol. Scand. 2009;120:27\u201329. doi: 10.1111/j.1600-0404.2009.01208.x.", "ArticleIdList": ["10.1111/j.1600-0404.2009.01208.x", "19566494"]}, {"Citation": "de Sa J.C.C., Airas L., Bartholome E., Grigoriadis N., Mattle H., Oreja-Guevara C., O\u2019Riordan J., Sellebjerg F., Stankoff B., Vass K. Symptomatic therapy in multiple sclerosis: A review for a multimodal approach in clinical practice. Ther. Adv. Neurol. Disord. 2011;4:139\u2013168. doi: 10.1177/1756285611403646.", "ArticleIdList": ["10.1177/1756285611403646", "PMC3105633", "21694816"]}, {"Citation": "Fong A., Chau C.T., Quant C., Duffy J., Pan D., Ogunyemi D.A. Multiple sclerosis in pregnancy: Prevalence, sociodemographic features, and obstetrical outcomes. J. Matern.-Fetal Neonatal Med. 2018;31:382\u2013387. doi: 10.1080/14767058.2017.1286314.", "ArticleIdList": ["10.1080/14767058.2017.1286314", "28139946"]}, {"Citation": "Axtell R.C., De Jong B.A., Boniface K., Van Der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G. T helper type 1 and 17 cells determine efficacy of interferon-\u03b2 in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010;16:406\u2013412. doi: 10.1038/nm.2110.", "ArticleIdList": ["10.1038/nm.2110", "PMC3042885", "20348925"]}, {"Citation": "Maggi P., Absinta M., Grammatico M., Vuolo L., Emmi G., Carlucci G., Spagni G., Barilaro A., Repice A.M., Emmi L. Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies. Ann. Neurol. 2018;83:283\u2013294. doi: 10.1002/ana.25146.", "ArticleIdList": ["10.1002/ana.25146", "PMC5901412", "29328521"]}, {"Citation": "Kotter M.R., Li W.-W., Zhao C., Franklin R.J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 2006;26:328\u2013332. doi: 10.1523/JNEUROSCI.2615-05.2006.", "ArticleIdList": ["10.1523/JNEUROSCI.2615-05.2006", "PMC6674302", "16399703"]}, {"Citation": "Krasnow A.M., Ford M.C., Valdivia L.E., Wilson S.W., Attwell D. Regulation of developing myelin sheath elongation by oligodendrocyte calcium transients in vivo. Nat. Neurosci. 2018;21:24\u201328. doi: 10.1038/s41593-017-0031-y.", "ArticleIdList": ["10.1038/s41593-017-0031-y", "PMC6478117", "29230052"]}, {"Citation": "Goldenberg M.M. Multiple sclerosis review. Pharm. Ther. 2012;37:175\u2013184.", "ArticleIdList": ["PMC3351877", "22605909"]}, {"Citation": "Gold R., Kappos L., Arnold D.L., Bar-Or A., Giovannoni G., Selmaj K., Tornatore C., Sweetser M.T., Yang M., Sheikh S.I., et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N. Engl. J. Med. 2012;367:1087\u20131097. doi: 10.1056/NEJMoa1114287.", "ArticleIdList": ["10.1056/NEJMoa1114287", "22992072"]}, {"Citation": "Calabresi P.A., Kieseier B.C., Arnold D.L., Balcer L.J., Boyko A., Pelletier J., Liu S., Zhu Y., Seddighzadeh A., Hung S., et al. Pegylated interferon \u03b2-1a for relapsing-remitting multiple sclerosis (ADVANCE): A randomised, phase 3, double-blind study. Lancet Neurol. 2014;13:657\u2013665. doi: 10.1016/S1474-4422(14)70068-7.", "ArticleIdList": ["10.1016/S1474-4422(14)70068-7", "24794721"]}, {"Citation": "Ascherio A., Munger K.L., White R., K\u00f6chert K., Simon K.C., Polman C.H., Freedman M.S., Hartung H.P., Miller D.H., Montalb\u00e1n X., et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014;71:306\u2013314. doi: 10.1001/jamaneurol.2013.5993.", "ArticleIdList": ["10.1001/jamaneurol.2013.5993", "PMC4000029", "24445558"]}, {"Citation": "Shaygannejad V., Janghorbani M., Ashtari F., Zakeri H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study. Neurol. Res. 2012;34:854\u2013858. doi: 10.1179/1743132812Y.0000000081.", "ArticleIdList": ["10.1179/1743132812Y.0000000081", "22979982"]}, {"Citation": "Zarshenas M.M., Ansari R., Dadbakhsh A., Mohammadi M. A Review of Herbal Remedies for Multiple Sclerosis-Like Disorders in Traditional Persian Medicine (TPM) Curr. Drug Metab. 2018;19:392\u2013407. doi: 10.2174/1389200219666180305152057.", "ArticleIdList": ["10.2174/1389200219666180305152057", "29512456"]}, {"Citation": "Ahmad N., Tajuddin, Maheshwari V., Zaidi S., Nasiruddin M. Cardioprotective potential of hydro-alcoholic extract of Nepeta hindostana (roth) on isoproternol induced myocardial Infarction in rats. Iran. J. Pharm. Res. 2010;3:50. doi: 10.22037/ijpr.2010.441.", "ArticleIdList": ["10.22037/ijpr.2010.441"]}, {"Citation": "Joshi M., Kumar R., Prakash O., Pant A.K., Rawat D. Chemical composition and biological activities of Nepeta hindostana (Roth) Haines, Nepeta graciliflora Benth. and Nepeta cataria L. from India. J. Med. Herbs. 2021;12:35\u201346."}, {"Citation": "Yilmaz A., Boga M., Top\u00e7u G. Novel terpenoids with potential anti-alzheimer activity from Nepeta obtusicrena. Rec. Nat. Prod. 2016;10:530."}, {"Citation": "Tandon V.R., Gupta R.K. An experimental evaluation of anticonvulsant activity of Vitex-negundo. Indian J. Physiol. Pharmacol. 2005;49:199\u2013205.", "ArticleIdList": ["16170989"]}, {"Citation": "Gupta R.K., Tandon V.R. Antinociceptive activity of Vitex-negundo Linn leaf extract. Indian J. Physiol. Pharmacol. 2005;49:163\u2013170.", "ArticleIdList": ["16170984"]}, {"Citation": "Hu M., Li F., Wang W. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson\u2019s disease through PI3K/Akt signaling pathway. Drug Des. Dev. Ther. 2018;12:565. doi: 10.2147/DDDT.S156920.", "ArticleIdList": ["10.2147/DDDT.S156920", "PMC5859909", "29588573"]}, {"Citation": "Dharmasiri M., Jayakody J., Galhena G., Liyanage S., Ratnasooriya W. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J. Ethnopharmacol. 2003;87:199\u2013206. doi: 10.1016/S0378-8741(03)00159-4.", "ArticleIdList": ["10.1016/S0378-8741(03)00159-4", "12860308"]}, {"Citation": "Gill B.S., Mehra R., Kumar S. Vitex negundo and its medicinal value. Mol. Biol. Rep. 2018;45:2925\u20132934. doi: 10.1007/s11033-018-4421-3.", "ArticleIdList": ["10.1007/s11033-018-4421-3", "30311123"]}, {"Citation": "Mukherjee A., Namhata D. Medicinal plant lore of the tribals of Sundargarh district, Orissa. Ethnobotany. 1990;2:57\u201360."}, {"Citation": "Alagesaboopathi C. Ethnomedicinal plants and their utilization by villagers in Kumaragiri hills of Salem district of Tamilnadu, India. Afr. J. Tradit. Complementary Altern. Med. 2009;6:222\u2013227. doi: 10.4314/ajtcam.v6i3.57157.", "ArticleIdList": ["10.4314/ajtcam.v6i3.57157", "PMC2816461", "20448846"]}, {"Citation": "Panghal M., Arya V., Yadav S., Kumar S., Yadav J.P. Indigenous knowledge of medicinal plants used by Saperas community of Khetawas, Jhajjar District, Haryana, India. J. Ethnobiol. Ethnomed. 2010;6:4. doi: 10.1186/1746-4269-6-4.", "ArticleIdList": ["10.1186/1746-4269-6-4", "PMC2826346", "20109179"]}, {"Citation": "Khare C.P. Indian Medicinal Plants: An Illustrated Dictionary. Springer Science & Business Media; Berlin/Heidelberg, Germany: 2008."}, {"Citation": "Anarthe S., Chaudhari S. Neuropharmacological study of Argemone mexicana Linn. J. Appl. Pharm. Sci. 2011;1:121."}, {"Citation": "Rahiman R.A., Rajan N., Sreekumaran E. Neuroprotective Effect of vitex negundo against Scopolamine Induced Cognitive Impairment and Oxidative Stress in Wistar albino Rats. Biosci. Biotechnol. Res. Asia. 2015;12:301\u2013307. doi: 10.13005/bbra/2204.", "ArticleIdList": ["10.13005/bbra/2204"]}, {"Citation": "Anokwuru C., Anyasor G., Ajibaye O., Fakoya O., Okebugwu P. Effect of extraction solvents on phenolic, flavonoid and antioxidant activities of three nigerian medicinal plants. Nat. Sci. 2011;9:53\u201361."}, {"Citation": "Felts P.A., Woolston A.-M., Fernando H.B., Asquith S., Gregson N.A., Mizzi O.J., Smith K.J. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain. 2005;128:1649\u20131666. doi: 10.1093/brain/awh516.", "ArticleIdList": ["10.1093/brain/awh516", "PMC7109778", "15872019"]}, {"Citation": "Lassmann H., Kitz K., Wisniewski H. In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. Acta Neuropathol. 1981;55:297\u2013306. doi: 10.1007/BF00690994.", "ArticleIdList": ["10.1007/BF00690994", "7331770"]}, {"Citation": "Desai R.A., Davies A.L., Del Rossi N., Tachrount M., Dyson A., Gustavson B., Kaynezhad P., Mackenzie L., van der Putten M.A., McElroy D. Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis. Ann. Neurol. 2020;88:123\u2013136. doi: 10.1002/ana.25749.", "ArticleIdList": ["10.1002/ana.25749", "PMC7737229", "32293054"]}, {"Citation": "Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta. 1979;582:67\u201378. doi: 10.1016/0304-4165(79)90289-7.", "ArticleIdList": ["10.1016/0304-4165(79)90289-7", "760819"]}, {"Citation": "Aebi H. Methods of Enzymatic Analysis. Elsevier; Amsterdam, The Netherlands: 1974. Catalase; pp. 673\u2013684."}, {"Citation": "Kalousov\u00e1 M., Zima T., Tesar V., Lachmanov\u00e1 J. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purif. 2002;20:531\u2013536. doi: 10.1159/000066956.", "ArticleIdList": ["10.1159/000066956", "12566668"]}, {"Citation": "Moshage H., Kok B., Huizenga J.R., Jansen P.L. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin. Chem. 1995;41:892\u2013896. doi: 10.1093/clinchem/41.6.892.", "ArticleIdList": ["10.1093/clinchem/41.6.892", "7768008"]}, {"Citation": "Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979;95:351\u2013358. doi: 10.1016/0003-2697(79)90738-3.", "ArticleIdList": ["10.1016/0003-2697(79)90738-3", "36810"]}, {"Citation": "Bancroft J.D., Gamble M. Theory and Practice of Histological Techniques. Elsevier Health Sciences; Amsterdam, The Netherlands: 2008."}, {"Citation": "Zhao J., Bi W., Xiao S., Lan X., Cheng X., Zhang J., Lu D., Wei W., Wang Y., Li H., et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci. Rep. 2019;9:5790. doi: 10.1038/s41598-019-42286-8.", "ArticleIdList": ["10.1038/s41598-019-42286-8", "PMC6453933", "30962497"]}, {"Citation": "Hauser S.L., Oksenberg J.R. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron. 2006;52:61\u201376. doi: 10.1016/j.neuron.2006.09.011.", "ArticleIdList": ["10.1016/j.neuron.2006.09.011", "17015227"]}, {"Citation": "Mahad D., Ziabreva I., Lassmann H., Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain. 2008;131:1722\u20131735. doi: 10.1093/brain/awn105.", "ArticleIdList": ["10.1093/brain/awn105", "PMC2442422", "18515320"]}, {"Citation": "Rossi F., Marabese I., De Chiaro M., Boccella S., Luongo L., Guida F., De Gregorio D., Giordano C., de Novellis V., Palazzo E. Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions. J. Neurophysiol. 2014;111:2196\u20132209. doi: 10.1152/jn.00212.2013.", "ArticleIdList": ["10.1152/jn.00212.2013", "24304862"]}, {"Citation": "V\u00edctor V.M., Rocha M., De la Fuente M. Regulation of macrophage function by the antioxidant N-acetylcysteine in mouse-oxidative stress by endotoxin. Int. Immunopharmacol. 2003;3:97\u2013106. doi: 10.1016/S1567-5769(02)00232-1.", "ArticleIdList": ["10.1016/S1567-5769(02)00232-1", "12538039"]}, {"Citation": "Noguchi S., Nakatsuka M., Konishi H., Kamada Y., Chekir C., Kudo T. Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages. Int. Immunopharmacol. 2003;3:1335\u20131344. doi: 10.1016/S1567-5769(03)00146-2.", "ArticleIdList": ["10.1016/S1567-5769(03)00146-2", "12890431"]}, {"Citation": "Marrero M.B., Venema V.J., He H., Caldwell R.B., Venema R.C. Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1998;252:508\u2013512. doi: 10.1006/bbrc.1998.9678.", "ArticleIdList": ["10.1006/bbrc.1998.9678", "9826561"]}, {"Citation": "Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001;480\u2013481:243\u2013268. doi: 10.1016/S0027-5107(01)00183-X.", "ArticleIdList": ["10.1016/S0027-5107(01)00183-X", "11506818"]}, {"Citation": "Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science. 2005;310:1966\u20131970. doi: 10.1126/science.1119407.", "ArticleIdList": ["10.1126/science.1119407", "16373578"]}, {"Citation": "Kim S.H., Kim J., Sharma R.P. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol. Res. 2004;49:433\u2013439. doi: 10.1016/j.phrs.2003.11.004.", "ArticleIdList": ["10.1016/j.phrs.2003.11.004", "14998552"]}, {"Citation": "Guti\u00e9rrez-Venegas G., Maldonado-Fr\u00edas S., Ontiveros-Granados A., Kawasaki-C\u00e1rdenas P. Role of p38 in nitric oxide synthase and cyclooxygenase expression, and nitric oxide and PGE2 synthesis in human gingival fibroblasts stimulated with lipopolysaccharides. Life Sci. 2005;77:60\u201373. doi: 10.1016/j.lfs.2004.12.015.", "ArticleIdList": ["10.1016/j.lfs.2004.12.015", "15848219"]}, {"Citation": "Mossakowski A.A., Pohlan J., Bremer D., Lindquist R., Millward J.M., Bock M., Pollok K., Mothes R., Viohl L., Radbruch M. Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation. Acta Neuropathol. 2015;130:799\u2013814. doi: 10.1007/s00401-015-1497-x.", "ArticleIdList": ["10.1007/s00401-015-1497-x", "PMC4654749", "26521072"]}, {"Citation": "Miller J., Arrasate M., Brooks E., Libeu C.P., Legleiter J., Hatters D., Curtis J., Cheung K., Krishnan P., Mitra S. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat. Chem. Biol. 2011;7:925\u2013934. doi: 10.1038/nchembio.694.", "ArticleIdList": ["10.1038/nchembio.694", "PMC3271120", "22037470"]}, {"Citation": "Winyard P.G., Blake D.R. Antioxidants, redox-regulated transcription factors, and inflammation. Adv. Pharmacol. 1996;38:403\u2013421.", "ArticleIdList": ["8895818"]}, {"Citation": "Romanic A.M., Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 1994;4:145\u2013156. doi: 10.1111/j.1750-3639.1994.tb00825.x.", "ArticleIdList": ["10.1111/j.1750-3639.1994.tb00825.x", "8061860"]}, {"Citation": "Mancini A., Tantucci M., Mazzocchetti P., de Iure A., Durante V., Macchioni L., Giamp\u00e0 C., Alvino A., Gaetani L., Costa C. Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis. Neurobiol. Dis. 2018;113:97\u2013108. doi: 10.1016/j.nbd.2018.01.002.", "ArticleIdList": ["10.1016/j.nbd.2018.01.002", "29325869"]}, {"Citation": "Merrill J.E., Murphy S.P. Inflammatory events at the blood brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav. Immun. 1997;11:245\u2013263. doi: 10.1006/brbi.1997.0496.", "ArticleIdList": ["10.1006/brbi.1997.0496", "9512813"]}, {"Citation": "Oliveras-L\u00f3pez M.-J., Bern\u00e1 G., Jurado-Ruiz E., de la Serrana H.L.-G., Mart\u00edn F. Consumption of extra-virgin olive oil rich in phenolic compounds has beneficial antioxidant effects in healthy human adults. J. Funct. Foods. 2014;10:475\u2013484. doi: 10.1016/j.jff.2014.07.013.", "ArticleIdList": ["10.1016/j.jff.2014.07.013"]}, {"Citation": "Gonzalo-Gobernado R., Ayuso M.I., Sansone L., Bernal-Jim\u00e9nez J.J., Ramos-Herrero V.D., S\u00e1nchez-Garc\u00eda E., Ramos T.L., Abia R., Muriana F.J., Berm\u00fadez B. Neuroprotective effects of diets containing olive oil and DHA/EPA in a mouse model of cerebral ischemia. Nutrients. 2019;11:1109. doi: 10.3390/nu11051109.", "ArticleIdList": ["10.3390/nu11051109", "PMC6566717", "31109078"]}, {"Citation": "Yong H., Chartier G., Quandt J. Modulating inflammation and neuroprotection in multiple sclerosis. J. Neurosci. Res. 2018;96:927\u2013950. doi: 10.1002/jnr.24090.", "ArticleIdList": ["10.1002/jnr.24090", "28580582"]}, {"Citation": "Singh R.P., Sharad S., Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: Relevance of dietary antioxidants. J. Indian Acad. Clin. Med. 2004;5:218\u2013225."}, {"Citation": "Khodaei F., Khoshnoud M.J., Heidaryfar S., Heidari R., Karimpour Baseri M.H., Azarpira N., Rashedinia M. The effect of ellagic acid on spinal cord and sciatica function in a mice model of multiple sclerosis. J. Biochem. Mol. Toxicol. 2020;34:e22564. doi: 10.1002/jbt.22564.", "ArticleIdList": ["10.1002/jbt.22564", "32640490"]}, {"Citation": "Qi X., Lewin A.S., Sun L., Hauswirth W.W., Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Investig. Ophthalmol. Vis. Sci. 2007;48:681\u2013691. doi: 10.1167/iovs.06-0553.", "ArticleIdList": ["10.1167/iovs.06-0553", "17251466"]}, {"Citation": "Kumar A., Kaur V., Pandit K., Tuli H.S., Sak K., Jain S.K., Kaur S. Antioxidant Phytoconstituents From Onosma bracteata Wall. (Boraginaceae) Ameliorate the CCl4 Induced Hepatic Damage: In Vivo Study in Male Wistar Rats. Front. Pharmacol. 2020;11:1301. doi: 10.3389/fphar.2020.01301.", "ArticleIdList": ["10.3389/fphar.2020.01301", "PMC7472603", "32973525"]}, {"Citation": "Tasset I., Ag\u00fcera E., S\u00e1nchez-L\u00f3pez F., Feij\u00f3o M., Giraldo A.I., Cruz A.H., Gasc\u00f3n F., T\u00fanez I. Peripheral oxidative stress in relapsing\u2013remitting multiple sclerosis. Clin. Biochem. 2012;45:440\u2013444. doi: 10.1016/j.clinbiochem.2012.01.023.", "ArticleIdList": ["10.1016/j.clinbiochem.2012.01.023", "22330938"]}, {"Citation": "Hemmer B., Cepok S., Nessler S., Sommer N. Pathogenesis of multiple sclerosis: An update on immunology. Curr. Opin. Neurol. 2002;15:227\u2013231. doi: 10.1097/00019052-200206000-00001.", "ArticleIdList": ["10.1097/00019052-200206000-00001", "12045717"]}, {"Citation": "Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009;15:1546\u20131558. doi: 10.2174/138161209788168164.", "ArticleIdList": ["10.2174/138161209788168164", "19442172"]}, {"Citation": "Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181\u2013190. doi: 10.1016/S0092-8674(03)00521-X.", "ArticleIdList": ["10.1016/S0092-8674(03)00521-X", "12887920"]}, {"Citation": "Werner P., Pitt D., Raine C.S. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 2001;50:169\u2013180. doi: 10.1002/ana.1077.", "ArticleIdList": ["10.1002/ana.1077", "11506399"]}, {"Citation": "Rajda C., Pukoli D., Bende Z., Majl\u00e1th Z., V\u00e9csei L. Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis. Int. J. Mol. Sci. 2017;18:353. doi: 10.3390/ijms18020353.", "ArticleIdList": ["10.3390/ijms18020353", "PMC5343888", "28208701"]}, {"Citation": "Poddighe S., Murgia F., Lorefice L., Liggi S., Cocco E., Marrosu M.G., Atzori L. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis. Int. J. Biochem. Cell Biol. 2017;93:148\u2013155. doi: 10.1016/j.biocel.2017.07.004.", "ArticleIdList": ["10.1016/j.biocel.2017.07.004", "28720279"]}, {"Citation": "Mastronardi F.G., Noor A., Wood D.D., Paton T., Moscarello M.A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 2007;85:2006\u20132016. doi: 10.1002/jnr.21329.", "ArticleIdList": ["10.1002/jnr.21329", "17469138"]}, {"Citation": "Wood D.D., Ackerley C.A., Van Den Brand B., Zhang L., Raijmakers R., Mastronardi F.G., Moscarello M.A. Myelin localization of peptidylarginine deiminases 2 and 4: Comparison of PAD2 and PAD4 activities. Lab. Investig. 2008;88:354\u2013364. doi: 10.1038/labinvest.3700748.", "ArticleIdList": ["10.1038/labinvest.3700748", "18227806"]}, {"Citation": "Calabrese R., Zampieri M., Mechelli R., Annibali V., Guastafierro T., Ciccarone F., Coarelli G., Umeton R., Salvetti M., Caiafa P. Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood. Mult. Scler. J. 2012;18:299\u2013304. doi: 10.1177/1352458511421055.", "ArticleIdList": ["10.1177/1352458511421055", "21878453"]}, {"Citation": "Pritzker L.B., Joshi S., Gowan J.J., Harauz G., Moscarello M.A. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry. 2000;39:5374\u20135381. doi: 10.1021/bi9925569.", "ArticleIdList": ["10.1021/bi9925569", "10820008"]}, {"Citation": "Carrillo-Vico A., Leech M.D., Anderton S.M. Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system. J. Immunol. 2010;184:2839\u20132846. doi: 10.4049/jimmunol.0903639.", "ArticleIdList": ["10.4049/jimmunol.0903639", "20164413"]}, {"Citation": "Tranquill L.R., Cao L., Ling N.C., Kalbacher H., Martin R.M., Whitaker J.N. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult. Scler. J. 2000;6:220\u2013225. doi: 10.1177/135245850000600402.", "ArticleIdList": ["10.1177/135245850000600402", "10962541"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "27"}, {"Year": "2022", "Month": "2", "Day": "5"}, {"Year": "2022", "Month": "2", "Day": "18"}, {"Year": "2022", "Month": "3", "Day": "10", "Hour": "15", "Minute": "30"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35268709", "PMC8911946", "10.3390/molecules27051608", "molecules27051608"]}}], "PubmedBookArticle": []}